Commentary

On Thursday, officials at the Centers for Medicare and Medicaid Services announced that Medicare will limit coverage of Aduhelm, the first promising treatment for Alzheimer's in years, to patients participating in clinical trials. This precedent is devastating. By curtailing broad access to an FDA-approved medicine, Medicare...

There’s nothing ‘moderate’ about the suffering that will result from the supposed ‘middle ground’ between the status quo and a single-payer system. California officials have recently fined L.A. Care, America’s largest publicly operated health-insurance program, $55 million for letting poor Angelenos suffer and die as they...

House Democrats haven't given up on bringing socialized health care to the United States — at least judging from a hearing the Committee on Oversight and Reform held earlier this week. The event was titled "Examining Pathways to Universal Health Coverage." But for the committee's Democrats, the only...

California leads the nation in agricultural production. It’s no exaggeration to say this state feeds the world out of its fertile Central Valley. But that rich land has become a battlefield. California is the nation’s No. 1 state in agriculture commodity sales, with its share nearly double that...

Earlier this month, Rep. Frank Pallone, a New Jersey Democrat, introduced a bill that could restrict the Food and Drug Administration's "accelerated approval" pathway — the program responsible for bringing promising medicines to patients years ahead of schedule. The accelerated approval pathway is a rare example...